Responsive Image

 

 

Responsive Image

Enfermedades inmunomediadas

Líneas de investigación

  • Búsqueda de marcadores biológicos mediante proteómica y genética, para enfermedades autoinmunes sistémicas, con diferentes tipos de muestras, para diagnóstico y pronóstico. Trabajo realizado con el Cic bioGune y diferentes hospitales españoles.
  • Estudios genéticos y ecográficos de la arteria carótida en pacientes diagnosticados de patología musculo-esquelética reumática, para calcular del riesgo cardiovascular de éstos. Trabajo realizado en colaboración con varios hospitales españoles.
  • Registros epidemiológicos, de acontecimientos adversos, riesgo cardiovascular… en pacientes con enfermedades crónicas autoinmunes sistémicas y musculo-esqueléticas. En colaboración con la Sociedad Española de Reumatología y diferentes hospitales españoles.
  • Estudios epidemiológicos en patología reumática y enfermedad inflamatoria intestinal. En colaboración con el servicio de Aparato Digestivo de la OSI Bilbao-Basurto.
  • Utilización de Inteligencia Artificial para realizar estudios de diagnóstico y riesgo cardiovascular en patología inflamatoria y musculo-esquelética reumática. Trabajo conjunto con el servicio de radiodiagnóstico de la OSI Bilbao-Basurto e Ibermática i3B.
  • Estudios de nuevas estragáis y tecnologías para la implantación de servicios modernos de fácil acceso a los pacientes diagnosticados de enfermedades inflamatorias crónicas. Grupo de trabajo de los servicios de Reumatología de los Hospitales Galdakao y Basurto, informática y Araia SI.
  • Ensayos clínicos en todas las fases (l, II, III y IV) en patología Sistémica Autoinmune como Lupus Eritematoso Sistémico, Sindrome de Sjögren, Vasculitis Sistémicas como arteritis de células gigantes, patología musculo-esquelética como Artritis Reumatoide, Espondiloartropatías, enfermedades óseas como la osteoporosis… entre otros. Estudios impulsados por diferentes farmacéuticas.
Foto grupo

Actividades del grupo:

El servicio de Reumatología de la OSI Bilbao-Basurto actualmente tiene tres vertientes fundamentales: asistencial, docente e investigadora. En la rama de la actividad investigadora, desde hace más de 30 años se vienen desarrollando estudios epidemiológicos y ensayos clínicos, creando una sobrecarga para los médicos adjuntos. No fue hasta el año 2007 que se contrató mediante BIOEF, personal para crear una unidad de investigación clínica, estableciéndose en el año 2018 el grupo de enfermedades inmunomediadas del ISS Biocruces, que tiene básicamente dos líneas:

  • Ensayos clínicos en todas las fases (I, II, III, IV), tanto en patología autoinmune sistémica, como en patología musculo-esquelética.
  • Investigación Clínica. Realizamos diferentes estudios en búsqueda de biomarcadores mediante proteomica y genética, para el diagnóstico/pronostico tanto en patología autoinmune sistémica como diferentes vasculitis. Registros epidemiológicos de acontecimientos adversos debido a fármacos biológicos, estudios epidemiológicos en pacientes con Enfermedad Inflamatoria Intestinal, estudios de riesgo cardiovascular mediante ecografía y genética de la arteria carótida en pacientes con patología musculoesquelética y autoinmune sistémica. También se está desarrollando nuevas tecnologías telemáticas para facilitar el seguimiento cercano del personal sanitario a los pacientes crónicos. Por último, se está desarrollando herramientas mediante Inteligencia Artificial (IA) para el diagnóstico de patología inflamatoria reumática y la utilización de IAs para reducción del riesgo cardiovascular en pacientes reumáticos.

Todo este inmenso trabajo se puede realizar gracias a la colaboración y el trabajo en sinergia tanto del personal clínico del servicio como del investigador, para poder llevar a cabo los diferentes proyectos con los diferentes servicios de la OSI Bilbao-Basurto, diferentes farmacéuticas, Universidades, Hospitales y sociedades investigadoras.

Coordinador/a del grupo



Miembros del grupo

  María Carmen Muñoz Villafranca
 
 
  Eduardo Cuende Quintana
 
 
  Elena Cintora León
 
 
  Ignacio Torre Salaberri
 
 
  José Francisco García Llorente
 
 
  Natalia Andrea Rivera García
 
 
  Eva Galíndez Agirregoikoa
 
 
  Fernando Diez Renovales
 
 
  Olaia Begoña Fernández Berrizbeitia
 
 
  Maria Jesús Allande López-linares
 
 
  Clara Eugenia Pérez Velásquez
 
 
  María Esther Ruiz Lucea
 
 
  Silvia Pérez Barrio
 
 
  Juan María Blanco Madrigal
 
 
  Ana Rosa Intxaurbe Pellejero
 
 
  Jaime Cardenal Urdampilleta
 
 
  Clara Morandeira Arrizabalaga
 
 
  Ángel José Calderón García
 
 
  Nuria Vegas Revenga
 
 
  Martín Sáenz Aguirre
 
 
  María Enjuanes Noguero
 
 
  Estíbaliz Onís González
 
 
  Irati Urionagüena Onaindia
 
 
  Paula García Ledesma
 
 

Publicaciones del grupo

Herrero A,Martin JL,Castaneda S,Maiz O,Sanchez J,Ortego N et al. Biologic therapy in refractory Neurobehcet's disease: a multicenter study of 41 patients and literature review. Rheumatology (Oxford). 2022. IF:7,580. (1).

Gutierrez A,Zapater P,Ricart E,Gonzalez M,Gordillo J,Olivares D et al. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Front Med (Lausanne). 2022. 9. p. 823900-823900. IF:5,091. (1).

Gratacós J, Galíndez E, Otón T. Is Obesity a Predictor for Lack of Response to Treatment in Psoriatic Arthritis? A Systematic Review. Reumatol Clin. 2021; 17(5): 268-278. DOI:10.1016/j.reuma.2019.06.003.

de Toro J, Cea Calvo L, García Vivar ML, Pantoja L, Lerín Lozano C, García Díaz S et al. The Experience With Health Care of Patients With Inflammatory Arthritis: A Cross-sectional Survey Using the Instrument to Evaluate the Experience of Patients With Chronic Diseases. JCR-J Clin Rheumatol. 2021; 27(1): 25-30. DOI:10.1097/RHU.0000000000001155.

Martín Varillas JL, Atienza Mateo B, Calvo Rio V, Beltrán E, Sánchez Bursón J, Adán A et al. Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behcet Disease: National Study of 103 White Patients. J Rheumatol. 2021; 48(5): 741-750. DOI:10.3899/jrheum.200300.

Valero Jaimes JA, Lopez Gonzalez R, Martin Martinez MA, Garcia Gomez C, Sanchez Alonso F, Sanchez Costa JT et al. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project. J Clin Med. 2021; 10(3). DOI:10.3390/jcm10030382.

Gonzalez Mazon I, Rueda Gotor J, Ferraz Amaro I, Genre F, Corrales A, Calvo Rio V et al. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients. Semin Arthritis Rheum. 2021; 51(2): 395-403. DOI:10.1016/j.semarthrit.2021.02.003.

Prieto Pena D, Remuzgo Martinez S, Ocejo Vinyals JG, Atienza Mateo B, Genre F, Munoz Jimenez A et al. The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis. Clin Exp Rheumatol. 2021; 39 Suppl 129(2): 21-26.

Galindez Agirregoikoa E, Prieto Pena D, Martin Varillas JL, Joven B, Rusinovich O, Melero Gonzalez RB et al. Treatment with tofacitinib in refractory psoriatic arthritis. National multicenter study of the first 87 patients of clinical practice. J Rheumatol. 2021; 48(10): 1552-1558. DOI:10.3899/jrheum.201204.

Rueda Gotor J, Lopez Mejias R, Remuzgo Martinez S, Pulito Cueto V, Corrales A, Lera Gomez L et al. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study. Arthritis Res Ther. 2021; 23(1): 111-111. DOI:10.1186/s13075-021-02499-7.

Prieto Pena D, Remuzgo Martinez S, Ocejo Vinyals JG, Atienza Mateo B, Genre F, Jimenez AM et al. The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis. Clin Exp Rheumatol. 2021.

Fernandez O, Montalban X, Aladro Y, Alonso A, Arroyo R, Calles C et al. 13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I). Rev Neurologia. 2021; 72(11): 397-406. DOI:10.33588/rn.7211.2021172.

Prieto Pena D, Remuzgo Martinez S, Ocejo Vinyals JG, Atienza Mateo B, Genre F, Jimenez AM et al. The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis. Clin Exp Rheumatol. 2021; 39(2): 21-26.

Prior Espanol A, Sanchez Piedra C, Campos J, Manero FJ, Perez Garcia C, Bohorquez C et al. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry. Sci Rep. 2021; 11(1): 11091-11091. DOI:10.1038/s41598-021-90442-w.

Prieto Pena D, Genre F, Remuzgo Martinez S, Pulito Cueto V, Atienza Mateo B, Llorca J et al. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis. Sci Rep. 2021; 11(1): 11510-11510. DOI:10.1038/s41598-021-91055-z.

Maria Alvaro Gracia J, Francisco Garcia Llorente J, Valderrama M, Gomez S, Montoro M. Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review. Rheumatol Ther. 2021; 8(1): 17-40. DOI:10.1007/s40744-020-00258-9.

Alvaro Gracia JM, Barbazan C, Garcia Llorente JF, Munoz Fernandez S, Gomez Centeno A, Urruticoechea Arana A et al. Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis. Clin Exp Rheumatol. 2021.

Mayordomo L, Collada JM, Hernandez FMF, Bueno A, Insua Vilarino SA, Jimenez Nunez FG et al. Safety in the use of ultrasound in rheumatology during the COVID-19 Pandemic. Spanish Society of Rheumatology positioning paper. Reumatol Clin (Engl Ed). 2021; 17(5): 284-289. DOI:10.1016/j.reuma.2020.10.010.

Gómez Arango C, Gorostiza I, Úcar E, García Vivar ML, Pérez CE, De Dios JR et al. Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial. Rheumatol Ther. 2021; 8(3): 1323-1339. DOI:10.1007/s40744-021-00345-5.

Jose Calderon A, Irabien M. Endoscopic removal by ERCP of a foreign body (bullet) in the common bile duct. Gastrointest Endosc. 2021; 94(1): 194-195. DOI:10.1016/j.gie.2021.02.002.

Morandeira Arrizabalaga C. Rotations abroad: Professional enrichment guaranteed. Radiologia (Engl Ed). 2021; 63(4): 305-306. DOI:10.1016/j.rxeng.2020.05.005.

Fornell Perez R, Merino Bonilla JA, Morandeira Arrizabalaga C, Marin Diez E, Rovira A, Ros Mendoza LH. A bibliometric study of the journal Radiologia during the period 2010-2019. Radiologia. 2021; 63(3): 209-217. DOI:10.1016/j.rx.2021.02.002.

Pulito Cueto V, Remuzgo Martinez S, Genre F, Calvo Alen J, Aurrecoechea E, Llorente I et al. Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy. Clin Exp Rheumatol. 2021.

Julia A, Lopez Lasanta M, Blanco F, Gomez A, Haro I, Mas AJ et al. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskelet Disord. 2021; 22(1). DOI:10.1186/s12891-021-04248-y.

Cobo Ibanez T, Sanchez Piedra C, Nuno L, Castellvi I, Carrion Barbera I, Romero Bueno F et al. Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology. Reumatol Clin (Engl Ed). 2021. DOI:10.1016/j.reuma.2021.01.007.

Calvo I, Guerrero E, Ibarguengoitia O, Garcia Vivar ML, Fernandez O, Ruiz E et al. EXPERIENCE TO 6 YEARS IN THE MULTIDISCIPLINARY CONSULTATION OF PSORIASIS ARTHROPATHY IN A REFERENCE HOSPITAL. Clin Exp Rheumatol. 2021; 39(5): 1182-1182.

Calvo I, Ibarguengoitia O, Montero D, Vega L, Garcia Vivar ML, Ruiz E et al. FREQUENCY AND CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASE IN SPONDYLOARTHRITIS WITH BIOLOGICAL THERAPY. Clin Exp Rheumatol. 2021; 39(5): 1215-1215.

Calvo I, Ibarguengoitia O, Montero D, Vega L, Garcia CL, Garcia Vivar ML et al. STUDY OF PATIENTS TREATED WITH SECUKINUMAB IN THE SAME HOSPITAL THE LAST TWO YEARS. Clin Exp Rheumatol. 2021; 39(5): 1217-1217.

Prieto Pena D, Genre F, Remuzgo Martinez S, Pulito Cueto V, Atienza Mateo B, Llorca J et al. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (vol 11, 11510, 2021). Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-96114-z.

Prieto Pena D, Remuzgo Martinez S, Genre F, Pulito Cueto V, Atienza Mateo B, Llorca J et al. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis. Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-95762-5.

Rueda Gotor J, Lopez Mejias R, Remuzgo Martinez S, Pulito Cueto V, Lera Gomez L, Ladehesa Pineda L et al. VASPIN IN SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK IN AXIAL SPONDYLOARTHRITIS. Clin Exp Rheumatol. 2021; 39(5): 1184-1184.

Ferraz Amaro I, Rueda Gotor J, Genre F, Corrales A, Blanco R, Portilla V et al. Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis. 2021; 13. DOI:10.1177/1759720X211033755.

Prieto Pena D, Genre F, Martinez SR, Pulito Cueto V, Atienza Mateo B, Sevilla B et al. Vasculitis - aetiology, pathogenesis and animal models. Ann Rheum Dis. 2021; 80: 1076-1077. DOI:10.1136/annrheumdis-2021-eular.766.

Sanchez Bilbao L, Loricera J, Aldasoro V, Melero R, Castaneda S, Maiz O et al. TOCILIZUMAB IN VISUAL INVOLVEMENT OF GIANT CELL ARTERITIS. MULTICENTER STUDY OF 312 PATIENTS OF CLINICAL PRACTICE. Ann Rheum Dis. 2021; 80: 35-36. DOI:10.1136/annrheumdis-2021-eular.2169.

Sanchez Bilbao L, Loricera J, Aldasoro V, Melero R, Castaneda S, Maiz O et al. TOCILIZUMAB IN CRANIAL AND EXTRACRANIAL REFRACTORY GIANT CELL ARTERITIS: A MULTICENTER STUDY OF 312 CASES. Ann Rheum Dis. 2021; 80: 34-35. DOI:10.1136/annrheumdis-2021-eular.2139.

Trallero Araguas E, Romero F, Castellvi I, Ortiz Santamaria V, Castaneda S, Pernaute OS et al. EPIDEMIOLOGICAL AND CLINICAL DIFFERENCES BETWEEN ANTI-MDA5 PHENOTYPES: DATA FROM A LARGE COHORT (MEDRA5) STUDY. Ann Rheum Dis. 2021; 80: 700-700. DOI:10.1136/annrheumdis-2021-eular.3837.

Prieto Pena D, Martinez SR, Genre F, Pulito Cueto V, Atienza Mateo B, Sevilla B et al. BAFF-APRIL-BAFFR PATHWAY ON THE PATHOGENESIS OF IMMUNOGLOBULIN-A VASCULITIS. Ann Rheum Dis. 2021; 80: 267-268. DOI:10.1136/annrheumdis-2021-eular.707.

Gracia J, Sanchez Piedra C, Manero J, Ruiz Lucea ME, Lopez Vives L, Bohorquez C et al. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study. RMD Open. 2021; 7(3). DOI:10.1136/rmdopen-2021-001925.

Casbas AG, Zapater P, Ricart E, Gonzalez Vivo M, Gordillo J, Olivares D et al. Inflammatory bowel disease in immigrants to Spain: results of the EIIMIGRA study from GETECCU (ENEIDA registry). J Crohns Colitis. 2021; 15: 567-568.

Munoz Villafranca C, Ogueta MA, de la Piscina PR, Alvarez Herrero B, Loizate A, Gomez Zabala JM et al. Rescue treatment with original versus biosimilar infliximab in biologic-naive patients with moderate-severe Ulcerative Colitis and corticosteroid failure. J Crohns Colitis. 2021; 15: 475-475. DOI:10.1093/ecco-jcc/jjab076.612.

Munoz Villafranca C, Irabien M, Hernandez Aretxabaleta N, Arreba P, de Zarate JO, Garcia Gomez C et al. Association between anti-TNF alpha drug levels and drug-induced lupus in patients with Inflammatory Bowel Disease. J Crohns Colitis. 2021; 15: 281-282. DOI:10.1093/ecco-jcc/jjab076.360.

Munoz Villafranca C, Goiriena UA, Ispizua N, Munoz MI, Garcia N, de Zaratel JO et al. Potential biomarkers for diagnosis through proteomics, in patients with Inflammatory Bowel Disease. J Crohns Colitis. 2021; 15: 148-149. DOI:10.1093/ecco-jcc/jjab076.164.

Vegas Revenga N, Martin Varillas JL, Calvo Rio V, Gonzalez Mazon I, Sanchez Bilbao L, Beltran E et al. RAPID IMPROVEMENT IN CYSTOID MACULAR EDEMA WITH HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES. Ann Rheum Dis. 2021; 80: 1225-1226. DOI:10.1136/annrheumdis-2021-eular.3247.

Vegas Revenga N, Martin Varillas JL, Calvo Rio V, Gonzalez Mazon I, Sanchez Bilbao L, Beltran E et al. HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE INDUCES RAPID IMPROVEMENT OF VISUAL ACUITY IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES. Ann Rheum Dis. 2021; 80: 1412-1412. DOI:10.1136/annrheumdis-2021-eular.2159.

Vegas Revenga N, Martin Varillas JL, Calvo Rio V, Gonzalez Mazon I, Sanchez Bilbao L, Catalan EB et al. High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases. Arthritis Rheumatol. 2021; 73: 394-396.

Vegas Revenga N, Martin Varillas JL, Calvo Rio V, Gonzalez Mazon I, Sanchez Bilbao L, Catalan EB et al. Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases. Arthritis Rheumatol. 2021; 73: 396-398.

De Miguel E, Sanchez Costa JT, Narvaez J, Gonzalez Gay M, Garrido Punal N, Estrada Alarcon PV et al. Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry. Arthritis Rheumatol. 2021; 73: 328-330.

Sanchez Bilbao L, Loricera J, Castaneda S, Moriano C, Narvaez J, Aldasoro V et al. Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases. Arthritis Rheumatol. 2021; 73: 2940-2942.

Sanchez Bilbao L, Loricera J, Acha JPV, Moriano C, Narvaez J, Aldasoro V et al. Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice. Arthritis Rheumatol. 2021; 73: 2956-2958.

Sanchez Costa JT, Hernandez Rodriguez I, Fernandez E, Silva Diaz MT, Valero Jaimes JA, Gonzalez Fernandez I et al. Treatment of Giant Cell Arteritis in the ARTESER Multicenter Study of 1675 Patients. Arthritis Rheumatol. 2021; 73: 2946-2948.

Delmas AD, Sanchez Bilbao L, Calvo Rio V, Martinez Lopez D, Herrero Morant A, Galindez Agirregoikoa E et al. Uveitis in 406 Patients with Psoriatic Arthritis: Epidemiology, Clinical Characteristics and Relationship with Biological Treatment. Study of a Single University Center. Arthritis Rheumatol. 2021; 73: 2743-2745.

Montero D,Ibarguengoitia O,Vega L,Garcia CL,Calvo I,Blanco JM,Esther Ruiz M,Luz Garcia M,Galindez E,Inchaurbe AR,Fernandez O,Perez CE,Cuende E,Bilbao A,Torre I. Description of Risk Factors at Baseline and Need of Bone Agent According to Hadji Recommendations in Patients Taking Aromatase Inhibitors as Breast Cancer Therapy. Arthritis Rheumatol. 2020. 72. IF:9,586. (1).

Vega L,Calvo I,Ibarguengoitia O,Blanco JM,Montero D,Garcia CL,Esther Ruiz M,Inchaurbe AR,Torre I,Perez CE,Fernandez O,Cuende E,Gorostiza IR,Luz Garcia M,Galindez E. Real Life Severe Infections in Patients with Rheumatoid Arthritis on Treatment with Biological Therapy and JAK Inhibitors. Arthritis Rheumatol. 2020. 72. IF:9,586. (1).

Moriano C,Calvo J,Rua I,Diez E,Bermudez C,Lopez FJ,Galindo M,Olive A,Tomero E,Fernandez A,Freire M,Fernandez O,Perez A,Esther M,Marras Fernandez C,Montilla C,Santos G,Blanco R,Rodriguez M,Vela P,Lucica A,Javier F,Martinez V,Hernandez B,Andreu JL,Hernandez JA,Exposito L,Menor R,Ibanez M,Castellvi I,Galisteo C,Raya E,Quevedo VE,Vazquez T,Ibanez J,Maria Pego J. Factors Affecting Mortality of Systemic Lupus Erythematosus Patients in Spain in the 21st Century: Data from the RELESSER Registry. Arthritis Rheumatol. 2020. 72. IF:9,586. (1).

Gonzalez I,Rueda J,Ferraz I,Sanchez L,Martinez D,Genre F,Fontana NP,Calvo V,Remuzgo S,Pulito V,Corrales A,Lera L,Portilla V,Mata C,Hernandez V,Castaneda S,Francisca Vicente E,Fernandez C,Paz Martinez M,Castro D,Anino J,Carlos Quevedo J,Rodriguez C,Garcia ML,Galinez E,Fernandez C,Llorca J,Lopez R,Montes E,Peiteado D,Plasencia C,Balsa A,Barbarroja N,Ladehesa L,Ortega R,Collantes E,Blanco R,Angel Gonzalez M. Subclinical atherosclertoic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study with 806 patients. Arthritis Rheumatol. 2020. 72. IF:9,586. (1).

Gonzalez I,Ferraz I,Rueda J,Sanchez L,Martinez D,Agudo M,Genre F,Remuzgo S,Pulito V,Corrales A,Lera L,Portilla V,Calvo V,Mata C,Hernandez V,Castaneda S,Francisca Vicente E,Fernandez C,Paz Martinez M,Castro D,Anino J,Carlos Quevedo J,Rodriguez C,Fernandez C,Montes E,Garcia ML,Galinez E,Llorca J,Lopez R,Plasencia C,Peiteado D,Balsa A,Barbarroja N,Ladehesa L,Ortega R,Collantes E,Blanco R,Angel Gonzalez M. Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A mutlicenter study with 806 patients. Arthritis Rheumatol. 2020. 72. IF:9,586. (1).

Collia A,Garcia JM,Rivera P,Fernandez P,Rodrigo P,Torre I,Castillo B,Gomez JJ,Gil MDC,Garcia JC. Recurrent Vertebrobasilar Strokes Associated With Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE). Neurologist. 2020. 25. (5):p. 131-136. .

Yanez L,de Ceniga MV,Blanco J,Gonzalez A,Estallo L. Combined treatment of dysphagia lusoria and concomitant ipsilateral carotid artery stenosis. Angiologia. 2020. 72. (5):p. 269-272. .

Sanchez L,Martinez D,Revenga M,Lopez A,Valls E,Atienza B,Valls B,Maiz O,Blanco A,Torre I,Rodriguez V,Garcia A,Veroz R,Jovani V,Peiteado D,Sanchez M,Tomero E,Toyos FJ,Pinillos V,Aurrecoechea E,Mora A,Conesa A,Fernandez M,Troyano JA,Calvo V,Demetrio R,Gonzalez I,Hernandez JL,Castaneda S,Gonzalez MA,Blanco R. Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients. J. Clin. Med. 2020. 9. (9):2816. IF:3,303. (1).

Vela P,Sanchez C,Perez C,Castro MC,Freire M,Mateo L,Diaz C,Bohorquez C,Blanco JM,Ros I,Gomez S,Cano R,Sanchez F,Diaz F,Gomez JJ. Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: data from the BIOBADASER III register. Arthritis Res. Ther. 2020. 22. (1):p. 143-143. IF:5,156. (2).

Moriano C,Calvo J,Rua I,Alvarez ED,Bermudez C,Lopez FJ,Galindo M,Olive A,Muriel ET,Fernandez A,Gonzalez MF,Fernandez O,Gomez AP,Isacelaya EU,Cid CMF,Montilla CA,Soler GS,Blanco R,Rodiguez M,Vela P,Boteanu A,Narvaez J,Taboada VM,Hernandez B,Andreu JL,Beriain J,Exposito L,Menor R,Barcelo MI,Castellvi I,Galisteo C,Raya E,Vila VQ,Rodriguez TV,Ibanez J,Pego JM. FACTORS AFFECTING MORTALITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN SPAIN IN THE 21ST CENTURY: DATA FROM THE RELESSER REGISTRY. Ann. Rheum. Dis. 2020. 79. p. 1049-1050. IF:19,103. (1).

Narvaez J,Sanchez C,Fernandez M,Martinez V,Olive A,Rosas J,Garcia A,Judez E,Ruiz E,Romani L,Andreu JL,SJONGRENSER P. RISK FACTORS ASSOCIATED WITH RENAL INVOLVEMENT IN PRIMARY SJOGREN'S SYNDROME: DATA FROM THE SPANISH SJOGRENSER COHORT. Ann. Rheum. Dis. 2020. 79. p. 670-671. IF:19,103. (1).

Sanchez L,Martinez D,Atienza B,Martin JL,Calvo V,Demetrio R,Calderon M,Prieto D,Gonzalez I,Valls E,Valls B,Maiz O,Blanco A,Torre I,Rodriguez V,Garcia A,Veroz R,Jovani V,Peiteado D,Castaneda S,Sanchez M,Muriel ET,Saenz de Miera FJT,Pinillos V,Aurrecoechea E,Mora A,Conesa A,Fernandez M,Troyano JA,Revenga M,Hernandez JL,Gonzalez A,Blanco R. TOCILIZUMAB IN GRAVES' ORBITOPATHY. MULTICENTER STUDY OF 48 PATIENTS. Ann. Rheum. Dis. 2020. 79. p. 846-847. IF:19,103. (1).

Pulito V,Remuzgo S,Genre F,Calvo J,Aurrecoechea E,Llorente I,Triguero A,Blanco R,Llorca J,Ruiz E,Rivera N,Gualillo O,Lopez R,Castaneda S,Gonzalez MA. Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2020. IF:4,473. (2).

Fernandez O,Aladro Y,Arroyo R,Brieva LL,Calles MC,Carrascal P,Comabella M,Costa L,Eichau S,Garcia JA,Ginestal R,Gonzalez I,Izquierdo G,Martinez ML,Meca JE,Mendibe MM,Oterino A,Prieto JM,Rio J,Ramio LL,Romero L,Tellez N,Rodriguez A. [12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)]. Rev. Neurologia. 2020. 70. (10):p. 379-390. IF:0,870. (4).

Lopez R,Genre F,Remuzgo S,Pulito V,Sevilla B,Llorca J,Ortego N,Mijares V,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Navas A,Sanchez J,de Argila D,Rubio E,Leon M,Blanco JM,Galindez E,Martin J,Blanco R,Castaneda S,Gonzalez MA. Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):p. 166-170. IF:4,473. (2).

Genre F,Remuzgo S,Prieto D,Atienza B,Pulito V,Llorca J,Sevilla B,Ortego N,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Navas A,Sanchez J,de Argila D,Rubio E,Leon M,Blanco JM,Galindez E,Blanco R,Gualillo O,Martin J,Castaneda S,Gonzalez MA,Lopez R. Role of IRF5 in the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):p. 182-187. IF:4,473. (2).

Calderon M,Castaneda S,Aldasoro V,Villa I,Prieto D,Atienza B,Patino E,Moriano C,Romero S,Narvaez J,Gomez C,Perez E,Melero R,Becerra E,Revenga M,Alvarez N,Galisteo C,Sivera F,Olive A,Alvarez Del Buergo M,Marena L,Fernandez C,Navarro F,Raya E,Galindez E,Arca B,Solans R,Conesa A,Hidalgo C,Vazquez C,Roman JA,Loricera J,Lluch P,Manrique S,Vela P,De Miguel E,Torres C,Nieto JC,Ordas C,Salgado E,Luna C,Toyos FJ,Fernandez N,Garcia A,Larena C,Gonzalez C,Corrales A,Varela M,Aurrecoechea E,Dos R,Garcia A,Ortego N,Fernandez S,Ortiz F,Corteguera M,Hernandez JL,Gonzalez MA,Blanco R. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):p. 112-119. IF:4,473. (2).

Queiro R,Coto P,Joven B,Rivera R,Navío T,de la Cueva P,Alvarez JL,Narváez B,Rodriguez FJ,Pardo J,Feced C,Pujol C,Rodríguez J,Notario J,Pujol M,García M,Galindez E,Pérez S,Urruticoechea A,Hergueta M,López MD,Vélez García A,Maceiras F,Rodríguez L,Rubio E,Rodríguez Fernandez Freire L,Luelmo J,Gratacós J. Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project. Reumatol. Clin. 2020. 16. (1):p. 24-31. .

Sanz J,Beltrán E,Díaz MC,Fernández C,Galíndez E,García C,Gratacós J,Medina J,Queiro R,Ramírez J,Reina D,Rodríguez C,Rodríguez FJ,Rubio E,Veroz R. Quality Standard for the Management of Patients with Psoriatic Arthritis: QUANTUM Project. Reumatol. Clin. 2020. 16. (3):p. 203-215. .

Hernandez B,Alonso F,Calvo J,Pego JM,Lopez FJ,Galindo M,Olive A,Tomero E,Horcada L,Uriarte E,Erausquin C,Sanchez A,Montilla C,Santos G,Fernandez A,Blanco R,Rodriguez M,Vela P,Freire M,Diez E,Boteanu AL,Narvaez J,Martinez V,Ruiz E,Andreu JL,Fernandez O,Hernandez JA,Gantes M,Perez JJ,Ibanez M,Pecondon A,Marras C,Bonilla G,Castellvi I,Moreno M,Raya E,Quevedo VE,Vazquez T,Ruan JI,Munoz S,Rua I,RELESSER Spanish Soc R. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry). Lupus. 2020. 29. (1):p. 27-36. IF:2,911. (3).

Lopez R,Genre F,Remuzgo S,Pulito V,Sevilla B,Llorca J,Ortego N,Mijares V,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Navas A,Sanchez J,de Argila D,Rubio E,Leon M,Blanco JM,Galindez E,Martin J,Blanco R,Castaneda S,Gonzalez MA. Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):IF:4,473. (2).

Genre F,Remuzgo S,Prieto D,Atienza B,Pulito V,Llorca J,Sevilla B,Ortego N,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Navas A,Sanchez J,de Argila D,Rubio E,Leon M,Blanco JM,Galindez E,Blanco R,Gualillo O,Martin J,Castaneda S,Gonzalez MA,Lopez R. Role of IRF5 in the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):IF:4,473. (2).

Torrente V,Salman TC,Rua I,Del Campo V,Lopez FJ,Galindo M,Calvo J,Olive A,Mourino C,Horcada L,Bohorquez C,Montilla C,Salgado E,Diez E,Blanco R,Andreu JL,Fernandez O,Exposito L,Gantes M,Hernandez B,Pecondon A,Lozano N,Bonilla G,Lois A,Rubio P,Ovalles J,Tomero E,Boteanu A,Narvaez J,Freire M,Vela P,Quevedo V,Juan A,Munoz S,Raya E,Moreno M,Velloso ML,Soler G,Vazquez TR,Pego JM,RELESSER Group of the Spanish Society of Rheumatology (SER) and the S. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER). Semin. Arthritis Rheum. 2020. 50. (4):p. 657-662. IF:5,532. (1).

Riancho L,Martinez V,Rua I,Alonso F,Galindo M,Ovalles J,Olive A,Fernandez A,Calvo J,Menor R,Tomero E,Uriarte E,Botenau A,Andres M,Freire M,Santos G,Ruiz E,Ibanez M,Castellvi I,Galisteo C,Quevedo V,Raya E,Narvaez J,Exposito L,Hernandez JA,Horcada L,Aurrecoechea E,Pego JM. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality. Lupus. 2020. 29. (12):p. 1556-1565. IF:2,911. (3).

Pulito V,Remuzgo S,Genre F,Calvo J,Aurrecoechea E,Llorente I,Triguero A,Blanco R,Llorca J,Ruiz E,Rivera N,Gualillo O,Lopez R,Castaneda S,Gonzalez MA. Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2020. IF:4,473. (2).

Calderon M,Castaneda S,Aldasoro V,Villa I,Prieto D,Atienza B,Patino E,Moriano C,Romero S,Narvaez J,Gomez C,Perez E,Melero R,Becerra E,Revenga M,Alvarez N,Galisteo C,Sivera F,Olive A,Alvarez Del Buergo M,Marena L,Fernandez C,Navarro F,Raya E,Galindez E,Arca B,Solans R,Conesa A,Hidalgo C,Vazquez C,Roman JA,Loricera J,Lluch P,Manrique S,Vela P,De Miguel E,Torres C,Nieto JC,Ordas C,Salgado E,Luna C,Toyos FJ,Fernandez N,Garcia A,Larena C,Gonzalez C,Corrales A,Varela M,Aurrecoechea E,Dos R,Garcia A,Ortego N,Fernandez S,Ortiz F,Corteguera M,Hernandez JL,Gonzalez MA,Blanco R. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin. Exp. Rheumatol. 2020. 38 Suppl 124. (2):IF:4,473. (2).

Prieto D,Remuzgo S,Ocejo JG,Atienza B,Munoz A,Ortiz F,Romero S,Moriano C,Galindez E,Miranda JA,Blanco R,Gualillo O,Martin J,Castaneda S,Lopez R,Gonzalez MA. Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association. Semin. Arthritis Rheum. 2020. 50. (5):p. 897-901. IF:5,532. (1).

Fernandez C,Tornero C,Castro MC,Galindez E,Garcia JF,Garcia ML,Joven B,Juanola X,Urrego C,Lopez C,Almodovar R,Martinez N,Ruiz T,de Miguel E,ESPERANZA G. No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort. RMD Open. 2020. 6. (2):e001345. IF:5,117. (2).
Acebes C,Andreu JL,Balsa A,Batlle E,de Toro J,Llorente FG,Hernandez MV,Fernandez B,Hidalgo C,Mayordomo L,Naredo E,Narvaez FJ,Ortiz AM,Pablos JL,Perez T,Rodriguez C,Sanchez O,Uson J,Negron JB,Loza E,Carmona L,Castro SG,Alvarez MM. "There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective. Clin. Exp. Rheumatol. 2020. 38. (1):p. 82-87. IF:4,473. (2).

Lopez R,Genre F,Remuzgo S,Pulito V,Sevilla B,Llorca J,Ortego N,Mijares V,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Parejo AN,Perez JS,de Argila D,Rubio E,Luque ML,Blanco JM,Galindez E,Martin J,Blanco R,Castaneda S,Gonzalez MA. Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38. (2):p. 166-170. IF:4,473. (2).

Genre F,Remuzgo S,Prieto D,Atienza B,Pulito V,Llorca J,Sevilla B,Ortego N,Lera L,Leonardo MT,Penalba A,Cabero MJ,Martin L,Miranda JA,Parejo AN,Perez JS,de Argila D,Rubio E,Luque ML,Blanco JM,Galindez E,Blanco R,Gualillo O,Martin J,Castaneda S,Gonzalez MA,Lopez R. Role of IRF5 in the pathogenesis of immunoglobulin-A vasculitis. Clin. Exp. Rheumatol. 2020. 38. (2):p. 182-187. IF:4,473. (2).

Irabien M,Arreba P,Ortiz de Zarate J,Hernandez N,de la Maza S,Ispizua N,Munoz C. Ustekinumab Treatment for Toxic Megacolon in Severe Colonic Crohn's Disease: First Case Report. Rev. Esp. Enferm. Dig. 2020. 113. (3):p. 189-192. IF:2,086. (4).

Calderon M,Castaneda S,Aldasoro V,Villa I,Prieto D,Atienza B,Patino E,Moriano C,Romero S,Narvaez J,Gomez C,Perez E,Melero R,Becerra E,Revenga M,Alvarez N,Galisteo C,Sivera F,Olive A,Buergo MAD,Marena L,Fernandez C,Navarro F,Raya E,Galindez E,Arca B,Solans R,Conesa A,Hidalgo C,Vazquez C,Roman JA,Loricera J,Lluch P,Manrique S,Vela P,Miguel E,Torres C,Nieto JC,Ordas C,Salgado E,Luna C,Miera FJTD,Fernandez N,Garcia A,Larena C,Gonzalez C,Corrales A,Varela M,Aurrecoechea E,Santos RD,Garcia A,Ortego N,Fernandez S,Ortiz F,Corteguera M,Hernandez JL,Gonzalez MA,Blanco R. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice. Clin. Exp. Rheumatol. 2020. 38. (2):p. 112-119. IF:4,473. (2).

Silva L,Otón T,Askanase A,Carreira P,López FJ,Olivé A,Rúa Í,Narváez J,Ruiz E,Andrés M,Calvo E,Toyos F,Alegre JJ,Tomero E,Montilla C,Zea A,Uriarte E,Calvo J,Marras C,Martínez VM,Belmonte MÁ,Rosas J,Raya E,Bonilla G,Freire M,Pego JM,Millán I,Hughes A.Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.Reumatol Clin.2019.15.1.34-42.

Martínez P,Galve E,Arrazubi V,Sala MÁ,Fernández S,Pérez CE,Arango JF,Torre I.Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors.Reumatol Clin.2019.15.4.211-217.

Lopez R,Carmona FD,Genre F,Remuzgo S,Gonzalez C,Corrales A,Vicente EF,Pulito V,Miranda JA,Huaranga M,Blanco R,Robustillo M,Rodriguez J,Alperi M,Alegre JJ,Mijares V,Lera L,Perez E,Gonzalez A,Ortega R,Lopez C,Vivar MLG,Gomez C,Raya E,Narvaez J,Balsa A,Lopez FJ,Carreira P,Gonzalez I,Rodriguez L,Fernandez B,Ferraz I,Gualillo O,Castaneda S,Martin J,Llorca J,Gonzalez MA.Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.Arthritis Rheumatol..2019.71.3.351-360.9,586.1.

Queiro R,Laiz A,Seoane D,Galindez E,Montilla C,Park HS,Bethencourt JJ,Bustabad S,Pinto JA,Tejón P,Joven B,Ramírez J,Cuervo A,Cañete JD,Trenor P,Ordás C,Alonso S,García E,Toniolo E,Moreno MJ,Beteta MD,Lojo L,Navío T,Cebrián L,Barbazán C,Maceiras F,Rodriguez J,Steiner M,Muñoz S,Nóvoa FJ,León M,Rubio E,Medina J,Sánchez MD,Arévalo M,Gratacós J,Senabre JM,Rosas JC,Santos G,Nieto JC,González C,López A,Álvarez C,Ruiz MD,Torrente V,Fernández C,Martínez MP,Jovani V,Urruticoechea A,Cabello Y,Toledo MD,Almodóvar R,Belmonte M,Notario I,Raya E,Grupo de Trabajo del Proyecto R.Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology.Reumatol Clin.2019.15.5.252-257.

Orozco D,de Toro J,Galindo MJ,Marín I,Casellas F,Fuster MJ,García ML,Hormigo A,Guilabert M,Sánchez N,Fernández G,Cea L.Healthcare Experience and their Relationship with Demographic, Disease and Healthcare-Related Variables: A Cross-Sectional Survey of Patients with Chronic Diseases Using the IEXPAC Scale.Patient.2019.12.3.307-317.3,226.1.

Rosas J,Sanchez C,Fernandez M,Andreu JL,Martinez V,Olive A,Menor R,Rodriguez B,Aparicio AG,Longo FJL,Manrique S,Vadillo J,Barato SG,Lopez R,Narvaez FJ,Galisteo C,Martin JG,Lucea ER,Naranjo A,Erausquin C,Rua I,Illera O,Romani L,Melchor S,Moreira B,Raya E,Lopez MR,Mourino C,Pego JM,Cid N,Judez E,Moriano C,Torrente V,Corominas H,Magallon BG,Astete CG,Castellvi I,Bohorquez C,Loricera J,Belzunegui J,Cobo T,SJOGRENSER G.ESSDAI activity index of the SJoGRENSER cohort: analysis and comparison with other European cohorts.Rheumatol Int.2019.39.6.991-999.1,984.3.

Almodóvar R,Bueno Á,Batlle E,Beltrán E,Bernabeu D,Castro C,Cepero A,Crespo C,Díez F,Fernández C,García F,Gil De Miguel A,Juanola X,Linares L,Montero Pérez R,Castro C,Moreno MJ,Moreno M,Navarro V,Pack C,Quiles C,Veintemillas M,Zarco P.Magnetic resonance imaging assessment in patients with axial spondyloarthritis: development of checklists for use in clinical practice..Rheumatol Int.2019.39.12.2119-2127.1,984.3.

Calderón M,Loricera J,Aldasoro V,Castañeda S,Villa I,Humbría A,Moriano C,Romero S,Narváez J,Gómez C,Pérez E,Melero R,Becerra E,Revenga M,Álvarez N,Galisteo C,Sivera F,Olivé A,Álvarez Del Buergo M,Marena L,Fernández C,Navarro F,Raya E,Galindez E,Arca B,Solans R,Conesa A,Hidalgo C,Vázquez C,Román JA,Lluch P,Manrique S,Vela P,De Miguel E,Torres C,Nieto JC,Ordas C,Salgado E,Luna C,Toyos FJ,Fernández N,García A,Larena C,Palmou N,Calvo V,Prieto D,González C,Corrales A,Varela M,Aurrecoechea E,Dos R,García Á,Ortego N,Fernández S,Ortiz F,Corteguera M,Hernández JL,González MÁ,Blanco R.Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice..Semin Arthritis Rheum.2019.49.1.126-135.4,751.1

.

Fernández C,Loricera J,Castañeda S,López R,Ojeda C,Olivé A,Rodríguez S,Carreira PE,Pérez T,Retuerto M,Cervantes EC,Flores BJ,Hernández B,Urruticoechea A,Maíz O,Arboleya L,Bonilla G,Hernández Í,Palma D,Delgado C,Expósito R,Ruibal A,Álvarez B,Blanco J,Bernal JA,Vela P,Rodríguez M,Fito C,Ortiz F,Narváez J,Moreno M,López M,Mena N,Aguilera C,Romero S,Ordóñez S,Villa I,Gonzélez MC,Mora V,Palmou N,Hernández JL,González MA,Blanco R.Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.Semin Arthritis Rheum.2018.48.1.22-27.5,072.1.

Gratacós J,Luelmo J,Rodríguez J,Notario J,Marco TN,de la Cueva P,Busquets MP,Font MG,Joven B,Rivera R,Vega JLA,Álvarez AJC,Parera RS,Carrascosa JCR,Martínez FJR,Sánchez JP,Olmos CF,Pujol C,Galindez E,Barrio SP,Arana AU,Hergueta M,Coto P,Queiro R.Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.Rheumatol Int.2018.38.6.1115-1124.2,200.3.

Martín JL,Calvo V,Beltrán E,Sánchez J,Mesquida M,Adán A,Hernandez MV,Garfella MH,Pascual EV,Martínez L,Sellas A,Cordero M,Díaz M,Gallego R,Salom D,Ortego N,García JL,Callejas J-L,Herreras JM,García Á,Maíz O,Blanco A,Torre I,Díaz D,Pato E,Aurrecoechea E,Caracuel MA,Gamero F,Minguez E,Carrasco C,Olive A,Vázquez J,Ruiz O,Manero J,Muñoz S,Martinez MG,Rubio E,Toyos FJ,López FJ,Nolla JM,Revenga M,González C,Loricera J,Atienza B,Demetrio R,Hernández JL,González MA,Blanco R.Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.Ophthalmology.2018.125.9.1444-1451.7,732.1.

Flórez MT,Almodóvar R,García F,Rodríguez AB,Carmona L,Pérez MÁ,Aboitiz J,Urruticoechea A,Rodríguez CJ,Castro C,Fernández C,de Miguel E,Galíndez E,Álvarez JL,Torre JC,Linares LF,Moreno M,Navarro V,Juanola X,Zarco P.The EJES-3D tool for personalized prescription of exercise in axial spondyloarthritis through multimedia animations: pilot study.Rheumatol Int.2018.38.7.1277-1284.2,200.3.

Deza G,Notario J,Ferran M,Beltrán E,Almirall M,Alcalá R,Ruiz JC,Sánchez R,Pérez S,García ML,Galíndez E,Mora M,Rodríguez J,Gallardo F.Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain.Rheumatol Int.2018.38.11.2037-2043.2,200.3.

Torrente V,Salman TC,Rúa I,De Uña J,Balboa V,López FJ,Galindo M,Calvo J,Olivé A,Mouriño C,Horcada L,Sánchez A,Montilla C,Salgado E,Díez E,Blanco R,Andreu JL,Fernández O,Hernández JA,Gantes M,Hernández B,Pecondón A,Marras C,Bonilla G,Pego JM,On behalf of the RELESSER Study Group of the Spanish Society of Rheumatology (.Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).Semin Arthritis Rheum.2018.70.9.1025-1029.5,072.1.

Narváez J,Borrell H,Sánchez F,Rúa I,López FJ,Galindo M,Calvo J,Fernández A,Olivé A,Andreu JL,Martínez V,Nolla JM,Pego JM,Vela P,Vals E,Cobo T,Bonilla G,García MJ,Diez E,Freire M,Gantes M,De La Peña PG,García R,Hernández JÁ,Horcada L,Ibañez J,Ibañez M,Marras C,Marenco JL,Castellví I,Montilla C,Moreno M,Pecondon Á,Lucea ER,Sánchez A,Santos G,Toyos F,Isacelaya EU,Vazquez T.Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort.Arthritis Res Ther.2018.20.1.280-280.4,148.2.

© 2022 IIS Biocruces Bizkaia